KAMISHIA PARHAM: Open Payments
NPI 1003241308 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$444 in 8 payments from 6 companies in 2025. Trend: 2023 $19 · 2024 $1,279 · 2025 $444
Food & beverage: $444
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $220 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $125 |
| Kestra Medical Technology Services, Inc. | 1 | $33 |
| BridgeBio Pharma, Inc. | 1 | $27 |
| Novartis Pharmaceuticals Corporation | 1 | $25 |
| SCPHARMACEUTICALS INC. | 1 | $14 |
Products named: LOKELMA, Assure WCD, Attruby, LEQVIO, FUROSCIX.
Industry payments across MD — which companies pay providers there.
